MIRA
NASDAQ · Pharmaceuticals
Mira Pharmaceuticals Inc
$0.99
-0.01 (-1.30%)
Open$1.01
Previous Close$1.00
Day High$1.01
Day Low$0.98
52W High$2.45
52W Low$0.90
Volume—
Avg Volume128.1K
Market Cap42.02M
P/E Ratio—
EPS$-0.40
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,233.3% upside
Current
$0.99
$0.99
Target
$23.03
$23.03
$12.17
$23.03 avg
$29.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.23M | 13.68M | 17.07M |
| Net Income | 2.05M | 2.22M | 2.28M |
| Profit Margin | 13.5% | 16.2% | 13.3% |
| EBITDA | 4.17M | 3.79M | 4.72M |
| Free Cash Flow | 3.12M | 1.71M | 2.33M |
| Rev Growth | +3.2% | +10.2% | +2.3% |
| Debt/Equity | 0.43 | 0.37 | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |